Prostate Cancer

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Delicia Honen Yard May 15, 2012

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. E. David Crawford, MD, head of urologic oncology at University of Colorado (UC) Hospital and an investigator at the UC Cancer Center, both in Aurora, and UC colleague Thomas W. Flaig, MD, recently published a review of these agents. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.

Prostate Cancer Outcome Not Tied to Complementary Medicine

May 07, 2012

Although widely used, complementary and alternative medicine (CAM) does not impact patient satisfaction with treatment or patient-reported outcomes after treatment for localized prostate cancer.

Vitamin D May Help Prostate Cancer Patients

Rosemary Frei, MSc May 05, 2012

Small study shows benefit, but some experts urge caution.

Selected Prostate Cancer Patients May Benefit from HIFU

John Schieszer May 04, 2012

High intensity focused ultrasound (HIFU) may provide an alternative to traditional treatment for localized prostate cancer. British researchers report this use of ultrasound may be high beneficial in a select group of prostate cancer patients.

Prostate Imaging System Receives FDA Approval

Stephan Cho May 02, 2012

The device may improve clinicians' ability to diagnose prostate cancer.

Prostate Cancer Screening: Moving Beyond PSA

Robert G. Uzzo, MD, FACS May 01, 2012

More than 1 million prostate biopsies are performed annually in the United States, predominantly driven by elevations in PSA.

After Radical Prostatectomy, Patient Learns He Never Had Prostate Cancer

Ann W. Latner, JD May 01, 2012

Dr. B, 57, was a urologist with a busy private practice. One of his patients was Mr. O, 69, who had an abnormal PSA result.

Radiotherapy Added to ADT Beneficial

Jody A. Charnow May 01, 2012

Adding radiotherapy to androgen deprivation therapy (ADT) improves outcomes in patients with locally advanced prostate cancer (PCa) and can be considered a standard treatment option.

Circumcision May Reduce PCa Risk

Jody A. Charnow April 28, 2012

Recent population-based study findings indicate that circumcision before first sexual intercourse is associated with a reduction in the relative risk of prostate cancer (PCa).

New Urine-Based Assay Helps Determine Need for Repeat Biopsy

John Schieszer April 25, 2012

A newly approved prostate cancer gene 3 assay may help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.

Peripheral Androgen Blockade Feasible for PSA Relapse

Jody A. Charnow April 24, 2012

Peripheral androgen blockade with a combination of finasteride and flutamide is feasible for prostate cancer patients who experience biochemical failure after definitive local therapy, researchers reported online ahead of print in Cancer.

Radical Surgery Hard to Justify for Low-Risk Prostate Cancer

Jody A. Charnow April 23, 2012

Radical prostatectomy (RP) for prostate cancer (PCa) is difficult to justify for patients with Gleason 6, T1 disease, researchers concluded.

New Oral Drug May Aid Survival in CRPC Patients

John Schieszer April 19, 2012

An investigational oral agent known as MDV-3100, which halts androgen signaling, may significantly improve survival in men with metastatic castration-resistant prostate cancer (CRPC).

HIFU Focal Therapy May Be a Viable Option for Prostate Cancer

Jody A. Charnow April 18, 2012

Focal therapy for localized prostate cancer is associated with a low rate of erectile problems and urinary incontinence a year after treatment, according to a small prospective study.

Perineural Invasion Predicts PSA Relapse After Brachytherapy

Jody A. Charnow April 16, 2012

Perineural invasion (PNI) and post-treatment PSA levels at 12 months strongly predict long-term PSA relapse-free survival (PRFS) after definitive brachytherapy seed implantation for prostate cancer (PCa), according to a study.

BMD Loss Occurs Early in Androgen Deprivation Therapy

April 12, 2012

Study finds loss evident in men treated with ADT for nonmetastatic, hormone-sensitive prostate cancer

BPH Drugs Found to Decrease PSA Doubling Times

John Schieszer April 12, 2012

Men with prostate cancer on active surveillance (watchful waiting) may benefit from treatment with finasteride or dutasteride.

Irbesartan May Preserve Erectile Function After RRP

Jody A. Charnow April 10, 2012

Regular irbesartan use after nerve-sparing radical retropubic prostatectomy (RRP) could improve postoperative recovery of erectile function among patients with normal preoperative erectile function, according to researchers.

Should percent free PSA be used in the decision to perform initial prostate biopsy in men with moderately elevated PSA?

Jody A. Charnow April 06, 2012

A recently published paper reported on the development of an improved nomogram for predicting outcomes of initial biopsies based on readily available clinical information.

Brachytherapy May Be Underused

John Schieszer April 06, 2012

Brachytherapy appears to have significant advantages over EBRT in the treatment of men with low-risk and intermediate-risk prostate cancer.

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront

Sickle Cell Trait and Medullary Renal Carcinoma

A 55-year-old Caucasian woman initially presented to one of Cleveland Clinic's regional outpatient urology clinics with gross hematuria and an obstructing right ureteral stone.

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Managing Bone Disease in  Kidney Transplant Recipients

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.